Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Prenosis $20M Series AAntheia $24M Series C second closeRanked by rounds participated in, from announcements in Jan 1, 2026 – Oct 24, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Prenosis $20M Series AAntheia $24M Series C second closeNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
AON3D Undisclosed InvestmentSkyFi $12.7M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Gyde $60M UndisclosedPrudentia Sciences $20M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Cellares $257M Series DKinaset Therapeutics $103M Series BNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Summize $50M UndisclosedTeamFeePay £9M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Neurophos $110M Series ASage Geosystems $97M Series BNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Preply $150M Series DHOLYWATER $22M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Fracttal $35M UndisclosedTucuvi $20M Series ANew companies 2 · Follow-on 0
Stages: Series B 2
Exciva €51M Series BKinaset Therapeutics $103M Series BNew companies 2 · Follow-on 0
Stages: Series A 2
Vibrant Therapeutics $61M Series ASpiro Medical $67M Series ANew companies 2 · Follow-on 0
Stages: Series A 2
Ventaris Surgical $30M Series AAirNexis Therapeutics $200M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.